References
- Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
- Saeg F , AnbalaganM. Breast cancer stem cells and the challenges of eradication: a review of novel therapies. Stem Cell Investig.5, 39 (2018).
- Gener P , RafaelDF de S, FernándezYet al. Cancer stem cells and personalized cancer nanomedicine. Nanomedicine (Lond.)11(3), 307–320 (2016).
- Xu X , ChaiS, WangPet al. Aldehyde dehydrogenases and cancer stem cells. Cancer Lett.369(1), 50–57 (2015).
- Mohammad Sultan KMC . Retinoid signaling in cancer and its promise for therapy. J. Carcinog. Mutagen.S7, 006 (2013).
- Vassalli G . Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells. Stem Cells Int.2019, doi: 10.1155/2019/3904645 (2019) ( Epub ahead of print).
- Ginestier C , WicinskiJ, CerveraNet al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle8(20), 3297–3302 (2009).
- Singh S , BrockerC, KoppakaVet al. Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress. Free Radic. Biol. Med.56, 89–101 (2013).
- Parajuli B , FishelML, HurleyTD. Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells. J. Med. Chem.57(2), 449–461 (2014).
- Weerawatanakorn M , WuJC, PanMH, HoCT. Reactivity and stability of selected flavor compounds. J. Food Drug Anal.23(2), 176–190 (2015).
- Naz F , KhanFI, MohammadTet al. Investigation of molecular mechanism of recognition between citral and MARK4: a newer therapeutic approach to attenuate cancer cell progression. Int. J. Biol. Macromol.107(Pt B), 2580–2589 (2018).
- Thomas ML , de AntuenoR, CoyleKMet al. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3. Mol. Oncol.10(9), 1485–1496 (2016).
- Ailincai D , PorzioW, MarinL. Hydrogels based on imino-chitosan amphiphiles as a matrix for drug delivery systems. Polymers (Basel)12(11), 2687 (2020).
- Nordin N , YeapSK, RahmanHSet al. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells. Sci. Rep.9(1), 1614 (2019).
- Nordin N , YeapSK, RahmanHSet al. Antitumor and anti-metastatic effects of citral-loaded nanostructured lipid carrier in 4T1-induced breast cancer mouse model. Molecules25(11), 2670 (2020).
- White B , EvisonA, DombiE, TownleyHE. Improved delivery of the anticancer agent citral using BSA nanoparticles and polymeric wafers. Nanotechnol. Sci. Appl.10, 163–175 (2017).
- Izham MNM , HussinY, AzizMNMet al. Preparation and characterization of self nano-emulsifying drug delivery system loaded with citraland its antiproliferative effect on colorectal cells in vitro. Nanomaterials9(7), 1028 (2019).
- Palmas L , AroffuM, PetrettoGLet al. Entrapment of Citrus limon var. pompia essential oil or pure citral in liposomes tailored as mouthwash for the treatment of oral cavity diseases. Pharmaceuticals (Basel)13(9), 216 (2020).
- Hwang D , RamseyJD, KabanovAV. Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval. Adv. Drug Deliv. Rev.156, 80–118 (2020).
- Ma P , GouS, MaYet al. Modulation of drug release by decoration with Pluronic F127 to improve anti-colon cancer activity of electrospun fibrous meshes. Mater. Sci. Eng. C99, 591–598 (2019).
- Menon JU , KonaS, WadajkarAS, DesaiF, VadlaA, NguyenKT. Effects of surfactants on the properties of PLGA nanoparticles. J. Biomed. Mater. Res. A100A(8), 1998–2005 (2012).
- Batrakova EV , LiS, ElmquistWF, MillerDW, AlakhovVY, KabanovAV. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br. J. Cancer85(12), 1987–1997 (2001).
- Ulldemolins A , Seras-FranzosoJ, AndradeFet al. Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics. Cancer Drug Resist.4, 44–68 (2021).
- Andrade F , RafaelD, Vilar-HernándezMet al. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. J. Control. Release331, 198–212 (2021).
- Andrade F , FonteP, CostaAet al. Pharmacological and toxicological assessment of innovative self-Assembled polymeric micelles as powders for insulin pulmonary delivery. Nanomedicine (Lond.)11(17), 2305–2317 (2016).
- Gener P , MonteroS, Xandri-MonjeHet al. Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells. Nanomedicine24, 102106 (2020).
- Gener P , GouveiaLP, SabatGRet al. Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells. Nanomedicine11(8), 1883–1892 (2015).
- Botella P , AbasoloI, FernándezYet al. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J. Control. Release156(2), 246–257 (2011).
- Rocas P , FernándezY, García-ArandaNet al. Improved pharmacokinetic profile of lipophilic anti-cancer drugs using ανβ3-targeted polyurethane-polyurea nanoparticles. Nanomedicine14(2), 257–267 (2018).
- Graham CE , BrocklehurstK, PickersgillRW, WarrenMJ. Characterization of retinaldehyde dehydrogenase 3. Biochem. J.394(1), 67–75 (2006).
- Eliceiri K , SchneiderCA, RasbandWS, EliceiriKW. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods9(7), 671–675 (2012).
- Gener P , Seras-FranzosoJ, CallejoPGet al. Dynamism, sensitivity, and consequences of mesenchymal and stem-like phenotype of cancer cells. Stem Cells Int.2018, 4516454 (2018).
- Sergeant G , VankelecomH, GremeauxL, TopalB. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat. Rev. Clin. Oncol.6(10), 580–586 (2009).
- Espinosa-Cano E , Huerta-MadroñalM, Cámara-SánchezPet al. Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways. Mater. Sci. Eng. C124, 112024 (2021).
- Ma F , LiH, LiYet al. Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC). Medicine (Baltimore)96(14), e6561 (2017).
- Maswal M , DarAA. Inhibition of citral degradation in an acidic aqueous environment by polyoxyethylene alkylether surfactants. Food Chem.138(4), 2356–2364 (2013).
- Nigjeh SE , YeapSK, NordinN, KamalideghanB, KyH, RosliR. Citral induced apoptosis in MDA-MB-231 spheroid cells. BMC Complement. Altern. Med.18(1), 56 (2018).
- Lee JS , KimWG. Potential protective effect of ALDH-1 stromal expression against early recurrence of operable breast cancers. Stem Cell Investig.5, 43 (2018).
- Croker AK , Rodriguez-TorresM, XiaYet al. Differential functional roles of ALDH1A1 and ALDH1A3 in mediating metastatic behavior and therapy resistance of human breast cancer cells. Int. J. Mol. Sci.18(10), 2039 (2017).
- Kim RJ , ParkJR, RohKJet al. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. Cancer Lett.333(1), 18–31 (2013).
- Clark DW , PalleK. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets. Ann. Transl. Med.4(24), 518 (2016).
- Uddin MH , KimB, ChoU, AzmiAS, SongYS. Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells. Heliyon6(11), e05442 (2020).
- Ciccone V , TerzuoliE, DonniniS, GiachettiA, MorbidelliL, ZicheM. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells. J. Exp. Clin. Cancer Res.37(1), 311 (2018).
- Nakahata K , UeharaS, NishikawaSet al. Aldehyde dehydrogenase 1 (ALDH1) is a potential marker for cancer stem cells in embryonal rhabdomyosarcoma. PLoS ONE10(4), e0125454 (2015).
- Liu P , KumarIS, BrownSet al. Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells. Br. J. Cancer109(7), 1876–1885 (2013).
- Barbuti AM , ChenZS. Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy. Cancers (Basel)7(4), 2360–2371 (2015).
- Yokoyama C , SueyoshiY, EmaM, MoriY, TakaishiK, HisatomiH. Induction of oxidative stress by anticancer drugs in the presence and absence of cells. Oncol. Lett.14(5), 6066–6070 (2017).
- Gener P , RafaelD, Seras-franzosoJet al. Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cells. Cancers (Basel)11(8), 1058 (2019).